Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

181. Benefits and Risks of Oral Diabetes Agents Compared With Insulin in Women With Gestational Diabetes: A Systematic Review (PubMed)

Benefits and Risks of Oral Diabetes Agents Compared With Insulin in Women With Gestational Diabetes: A Systematic Review Little is known about the comparative risks and benefits of medical treatments for gestational diabetes mellitus (GDM). We conducted a systematic review of randomized controlled trials and observational studies of maternal and neonatal outcomes in women with GDM treated with oral diabetes agents compared with all types of insulin.We searched four electronic databases from (...) (n=1,229 participants) and five observational studies (n=831 participants). Data were abstracted on study characteristics, gestational age at treatment, medication dosage, and length of follow-up. Outcomes included glycemic control, infant birth weight, neonatal hypoglycemia, and congenital anomalies.Two trials compared insulin to glyburide; one trial compared insulin, glyburide, and acarbose; and one trial compared insulin to metformin. No significant differences were found in maternal glycemic

2009 EvidenceUpdates

182. Screening for gestational diabetes

Screening for gestational diabetes Executive Summary IQWiG Reports – Commission No. S07-01 Screening for gestational diabetes 1 1 Translation of the executive summary of the final report “Screening auf Gestationsdiabetes” (Version 1.1; Status: 25.08.2009). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Executive summary of final report S07-01 Screening (...) for gestational diabetes Version 1.1 25.08.2009 Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Assessing the benefit and medical necessity of screening for gestational diabetes Contracting agency: Federal Joint Committee Commission awarded on: 10.05.2007 Internal Commission No.: S07-01 Publisher’s address: Institute for Quality and Efficiency in Health Care Dillenburger Str. 27 51105 Cologne Germany Tel.: +49 221 35685-0 Fax: +49 221 35685-1 berichte@iqwig.de

2009 Institute for Quality and Efficiency in Healthcare (IQWiG)

183. A multicenter, randomized trial of treatment for mild gestational diabetes. (PubMed)

A multicenter, randomized trial of treatment for mild gestational diabetes. It is uncertain whether treatment of mild gestational diabetes mellitus improves pregnancy outcomes.Women who were in the 24th to 31st week of gestation and who met the criteria for mild gestational diabetes mellitus (i.e., an abnormal result on an oral glucose-tolerance test but a fasting glucose level below 95 mg per deciliter [5.3 mmol per liter]) were randomly assigned to usual prenatal care (control group (...) %). Treatment of gestational diabetes mellitus, as compared with usual care, was also associated with reduced rates of preeclampsia and gestational hypertension (combined rates for the two conditions, 8.6% vs. 13.6%; P=0.01).Although treatment of mild gestational diabetes mellitus did not significantly reduce the frequency of a composite outcome that included stillbirth or perinatal death and several neonatal complications, it did reduce the risks of fetal overgrowth, shoulder dystocia, cesarean delivery

Full Text available with Trip Pro

2009 NEJM

184. A blood pressure before and during early pregnancy is associated with an increased risk of gestational diabetes mellitus (PubMed)

A blood pressure before and during early pregnancy is associated with an increased risk of gestational diabetes mellitus While women with prior gestational diabetes mellitus (GDM) are more likely to display features of the metabolic syndrome, including hypertension, in the years after delivery, it is unclear whether these components are also present before pregnancy. We examined the relationship between blood pressure (BP) measured before and during early pregnancy (<20 weeks) and the risk (...) of GDM in a nested case-control study.Case (n = 381) and control (n = 942) subjects were selected from a cohort of women delivering between 1996 and 1998 and screened for GDM between 24 and 28 weeks' gestation. GDM was defined by the National Diabetes Data Group criteria. BP and covariates data were obtained by review of the medical records. Women were categorized according to BP levels recommended by the American Heart Association outside of pregnancy: <120/80 mmHg (normal), 120-139/80-89 mmHg

Full Text available with Trip Pro

2008 EvidenceUpdates

185. Gestational Weight Gain and Gestational Diabetes Mellitus: Perinatal Outcomes (PubMed)

Gestational Weight Gain and Gestational Diabetes Mellitus: Perinatal Outcomes To examine the association between gestational weight gain and perinatal outcome in women with gestational diabetes mellitus (GDM).This is a retrospective cohort study of women with nonanomalous singleton pregnancies with GDM enrolled in the Sweet Success California Diabetes and Pregnancy Program between 2001 and 2004. Gestational weight gain, calculated from prepregnancy weight and weight at last prenatal Sweet (...) Success visit, was subgrouped into below, within, and above the Institute of Medicine (IOM) weight-gain guidelines. Perinatal outcomes were examined using chi2 test and multivariable regression analysis with 15-35-lb weight gain as the reference group.There were 31,074 women meeting study criteria. Compared with women with gestational weight gain within the IOM guidelines, women who gained above the guidelines had higher odds of having large for gestational age neonates (adjusted odds ratio [aOR] 1.72

Full Text available with Trip Pro

2008 EvidenceUpdates

186. Standards of medical care in diabetes. III. Detection and diagnosis of gestational diabetes mellitus (GDM).

Standards of medical care in diabetes. III. Detection and diagnosis of gestational diabetes mellitus (GDM). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines

2008 American Diabetes Association

187. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. (PubMed)

Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes.The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms (...) ) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks.Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).

2008 Annals of Internal Medicine

188. Dietary advice in pregnancy for preventing gestational diabetes mellitus. (PubMed)

Dietary advice in pregnancy for preventing gestational diabetes mellitus. Gestational diabetes mellitus (GDM) is a form of diabetes that occurs during pregnancy which can result in significant adverse outcomes for mother and child both in the short and long term. The potential for adverse outcomes, in addition to the increasing prevalence of gestational diabetes worldwide, demonstrates the need to assess strategies, such as dietary advice, that might prevent gestational diabetes.To assess (...) the effects of dietary advice in preventing gestational diabetes mellitus.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (January 2008) and reference lists of retrieved articles.Quasi-randomised and randomised studies of dietary intervention for preventing glucose intolerance in pregnancy.Two review authors independently conducted data extraction and quality assessment. We resolved disagreements through discussion or through a third author.Three trials (107 women) were included

Full Text available with Trip Pro

2008 Cochrane

189. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia (PubMed)

High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia The role of intrauterine hyperglycemia and future risk of type 2 diabetes in human offspring is debated. We studied glucose tolerance in adult offspring of women with either gestational diabetes mellitus (GDM) or type 1 diabetes, taking the impact of both intrauterine hyperglycemia and genetic predisposition to type 2 (...) diabetes into account.The glucose tolerance status following a 2-h 75-g oral glucose tolerance test (OGTT) was evaluated in 597 subjects, primarily Caucasians, aged 18-27 years. They were subdivided into four groups according to maternal glucose metabolism during pregnancy and genetic predisposition to type 2 diabetes: 1) offspring of women with diet-treated GDM (O-GDM), 2) offspring of genetically predisposed women with a normal OGTT (O-NoGDM), 3) offspring of women with type 1 diabetes (O-type 1

Full Text available with Trip Pro

2008 EvidenceUpdates

190. Metformin versus insulin for the treatment of gestational diabetes. (PubMed)

Metformin versus insulin for the treatment of gestational diabetes. Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking.We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia (...) outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin.In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).Copyright 2008 Massachusetts Medical Society.

Full Text available with Trip Pro

2008 NEJM

191. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson W K, Wilson L M, Witkop C T, Baptiste-Roberts K, Bennett W L, Bolen S, Barone B B, Golden S H, Gary T L, Neale D M, Bass E B CRD summary This review assessed treatment, delivery (...) options and subsequent testing for type-2 diabetes for women with gestational diabetes. The authors concluded that there was insufficient evidence to recommend insulin alternatives or to formulate delivery guidelines and the 75-gm OGTT test should be retained for post-partum testing. This was a well-conducted review. The conclusions reflected the limited evidence accurately and are likely to be reliable. Authors' objectives Identified objectives were: to determine the efficacy and safety of oral

2008 DARE.

192. The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research

The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research DiNallo J M, Downs D S CRD summary The authors concluded that exercise may have positive (...) and protective effects for the treatment and prevention of GDM (gestational diabetes mellitus). In view of poor reporting in the review, the small number of controlled studies, failure to assess or address heterogeneity between the studies and failure to systematically assess study quality, it is impossible to determine the reliability of the conclusions. Authors' objectives To assess the effects of exercise for treating, preventing or delaying GDM. Searching PsycLit, MEDLINE, Dissertation Abstracts Online

2008 DARE.

193. Screening for gestational diabetes mellitus

Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Hillier T A, Vesco K K, Whitlock E P, Pettitt D J, Pedula K L, Beil T L CRD summary The authors of this well-conducted review concluded that the limited evidence about early (<24 weeks) gestational diabetes mellitus (GDM) indicates a need for more research. The conclusion, which was based on one recent good-quality study in which screening identified women (...) with mild GDM after 24 weeks' gestation and improved maternal and neonatal outcomes, is likely to be reliable. Authors' objectives To evaluate the benefits and harms of screening for gestational diabetes mellitus (GDM). Searching MEDLINE, the Cochrane CENTRAL Register, the Cochrane Database of Systematic Reviews, DARE, HTA and the National Institute for Health and Clinical Excellence were searched from 2000 to September 2006l the search terms were reported. In addition, the reference lists from

2008 DARE.

194. Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes

Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes Article Text

2008 Evidence-Based Medicine (Requires free registration)

195. Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes

Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes Article Text Therapeutics Review: little evidence exists on the benefits

2008 Evidence-Based Medicine (Requires free registration)

196. Gestational Diabetes

Gestational Diabetes Horizon Scanning Technology Prioritising Summary Update Screening for gestational diabetes August 2008 © Commonwealth of Australia 2008 ISBN Publications Approval Number: This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from any use as permitted under the Copyright Act 1968, all other rights are reserved. Requests (...) , Mail Drop 545, University of Adelaide, Adelaide, SA, 5005. PRIORITISING SUMMARY UPDATE 2008 REGISTER ID: 000177 NAME OF TECHNOLOGY: SCREENING FOR GESTATIONAL DIABETES PURPOSE AND TARGET GROUP: DETECTION AND TREATMENT OF GESTATIONAL DIABETES MELLITUS IN PREGNANT WOMEN 2008 SAFETY AND EFFECTIVENESS ISSUES Since the original prioritising summary was published, there have been two studies investigating gestational hyperglycaemia which have reported their findings. A 5-year prospective observational

2008 Australia and New Zealand Horizon Scanning Network

197. Screening for gestational diabetes

Screening for gestational diabetes Screening for gestational diabetes Screening for gestational diabetes Liufu V, Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Liufu V, Mundy L, Hiller JE. Screening for gestational diabetes. Adelaide: Adelaide Health Technology Assessment (AHTA). Prioritising Summary. Volume 21. 2008 (...) Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestationals; Mass Screening; Pregnancy Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence Adelaide Health Technology Assessment, University of Adelaide, Discipline of Public Health, School of Population Health and Clinical Practice, Mail Drop DX650545, SA 5005 Adelaide Australia Email: tracy.merlin@adelaide.edu.au

2008 Health Technology Assessment (HTA) Database.

198. Screening for gestational diabetes mellitus

Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T. Screening for gestational diabetes (...) be to detect previously unrecognized diabetes (GDM is defined as onset or first recognition of diabetes during pregnancy). Therefore, more research is needed before this question can be evaluated. A recent good-quality randomized controlled trial reported that treatment of screen-detected women with mild GDM diagnosed after 24 weeks gestation reduces both maternal and composite neonatal health outcomes, without apparent harm—as reported in this RCT and in several other observational studies. Project page

2008 Health Technology Assessment (HTA) Database.

199. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB Citation Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K (...) , Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 162. 2008 Authors' objectives

We focused on four questions: (1) What are the risks and benefits of an oral diabetes agent (i.e., glyburide), as compared to all types of insulin, for gestational diabetes? (2) What

2008 Health Technology Assessment (HTA) Database.

200. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus (PubMed)

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus AIM: The efficacy and safety of insulin aspart (IAsp), a rapid-acting human insulin analogue, were compared with regular human insulin (HI) as the bolus component of basal-bolus therapy for subjects with gestational diabetes mellitus (GDM). METHODS: In a randomized, parallel-group, open-labelled trial, 27 women with GDM (age 30.7 +/- 6.3 years, HbA(1c

Full Text available with Trip Pro

2007 EvidenceUpdates